|
TCMBANKIN000080 |
Deoxycholic Acid |
SCHEMBL11962424; deoxycholic acid; Deoxycholicacid; deoxycholicacid; AKOS015965182; AC-20221 |
C24H40O4 |
392.57 |
CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C |
|
TCMBANKIN000805 |
desacetylanguidine |
|
C17H24O6 |
324.37 |
CC1=CC2C(CC1)(C3(C(C(C(C34CO4)O2)O)O)C)COC(=O)C |
|
TCMBANKIN001176 |
ganolucidic acid E |
|
C30H44O5 |
484.67 |
CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN001296 |
Tuberostemoenone |
tuberostemoenone; AC1NT1AO; azane; butane; methane; methanol; molecular hydrogen; trihydrate |
|
387.52 |
[HH].[HH].[HH].C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CCCC.CO.N.O.O.O |
|
TCMBANKIN001388 |
Ginsenoside-Rh4_qt |
|
C36H60O8 |
620.86 |
|
|
TCMBANKIN002103 |
ergosta-7,22-dien-3β,5α,6β-triol |
|
|
430.74 |
|
|
TCMBANKIN002133 |
Deoxyharringtonine |
Cephalotaxine, 4-methyl-, 2-hydroxy-2-(3-methylbutyl)butanedioate (ester), (3(R))-; NSC 142196; Cephalotaxine, 4-methyl-2-hydroxy-2-(3-methylbutyl)butanedioate (ester), (3(R))- (9CI); deoxyharringtonine |
C28H37NO8 |
515.6 |
CC(C)CCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O |
|
TCMBANKIN002233 |
(8R)-3-oxo-8-hydroxy-polypoda -13E,17E,21-triene |
|
|
442.8 |
|
|
TCMBANKIN002388 |
ginsenoside Rh7_qt |
|
|
474.8 |
|
|
TCMBANKIN002424 |
fischeriana B_qt |
|
C26H36O9 |
492.56 |
|
|
TCMBANKIN002465 |
(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one |
BB_NC-1001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; ZINC00001785 |
C15H12O5 |
272.25 |
|
|
TCMBANKIN002485 |
[(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[decalin-5,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
(E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1,2-dimethyl-1-[2-(5-oxo-2H-furan-3-yl)ethyl]-4a-spiro[decalin-5,2'-oxirane]yl]methyl ester; (E)-2-methylbut-2-enoic acid [(1S,2R,4S,4aR,5R,8aR)-4-hydroxy-1-[2-(5-keto-2H-furan-3-yl)ethyl]-1,2-dimethyl-spiro[decalin-5,2'-oxirane]-4a-yl]methyl ester; [(4R,4aR,5S,7R,8S,8aR)-5-hydroxy-7,8-dimethyl-8-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-4a-yl]methyl (E)-2-methylbut-2-enoate |
C25H36O6 |
432.55 |
|
|
TCMBANKIN002496 |
poriferasta-7,22E-dien-3beta-ol |
(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; LMST01040140; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,1R,4R)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(E,1R,4R)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C29H48O |
412.69 |
CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN002539 |
pelargonidin |
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1lambda-chromen-1-ylium; Pelargonidin-3,5-diglucoside_qt; 7690-51-9; C05904; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromenylium; XVFMGWDSJLBXDZ-UHFFFAOYSA-O; 3,4',5,7-Tetrahydroxyflavylium; anthocyanidin; pelargonidin 3,5-di-O-glycoside_qt; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium; CHEBI:25863; 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol; 2-(4-hydroxyphenyl)-1-benzopyrylium-3,5,7-triol; LMPK12010003; CHEMBL591036; pelargonidin-3-O-glucoside_qt; pelargonidin-3,5-di-O-glucoside_qt; BDBM50121994; CHEMBL1197905; A806724; BDBM50326998; 1-Benzopyrylium, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-; SCHEMBL20592; 134-04-3 (chloride); ZINC391840; Pelargonidin; AC1L9A0P; ZB012073 |
C15H11O5+ |
271.24 g/mol |
C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O |
|
TCMBANKIN002631 |
(8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
(8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C29H50O |
414.71 |
|
|
TCMBANKIN002824 |
glaucogenin,a |
glaucoside C_qt |
C41H62O15 |
794.92 |
|
|
TCMBANKIN002903 |
delta 5-Pregnenetriol |
(3S,8R,9S,10R,13S,14S,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol; 903-67-3; 5-Pregnene-3beta,17alpha,20alpha-triol; Pregn-5-ene-3,17,20-triol, (3beta,20S)-; Pregn-5-ene-3beta,17alpha,20alpha-triol |
C21H34O3 |
334.49 |
CC(C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O)O |
|
TCMBANKIN003024 |
16beta,17-dihydroxy-(-)-kauran-19-ate-beta-D-glucose ester_qt |
|
|
336.52 |
|
|
TCMBANKIN003665 |
evoden |
|
|
|
C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O |
|
TCMBANKIN003703 |
paryriogenin I |
|
|
422.71 |
|
|
TCMBANKIN004430 |
cynapanoside B_qt |
|
|
390.47 |
|
|
TCMBANKIN004484 |
vittadinoside_qt |
|
|
412.77 |
|
|
TCMBANKIN004652 |
2-[(1R)-2,2,3-trimethyl-1-cyclopent-3-enyl]ethanal |
ZINC01063075; 2-[(1R)-2,2,3-trimethyl-1-cyclopent-3-enyl]acetaldehyde |
C10H16O |
152.23 |
|
|
TCMBANKIN005142 |
cimilactone a_qt |
|
|
458.7 |
|
|
TCMBANKIN005420 |
periplocin_qt |
|
|
390.57 |
|
|
TCMBANKIN005702 |
(2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid |
(2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid; (2S,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-3,11,15-triketo-4,4,10,13,14-pentamethyl-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-4-keto-2-methyl-enanthic acid |
C30H42O7 |
514.65 |
|
|
TCMBANKIN005886 |
atratoglaucoside,b_qt |
|
|
374.47 |
|
|
TCMBANKIN006029 |
polygosides E_qt |
polygosides C_qt; polygosides D_qt |
|
412.67 |
|
|
TCMBANKIN006040 |
Rubrosterone |
rubrosterone |
C19H26O5 |
334.41 |
CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2=O)O |
|
TCMBANKIN006050 |
parkeol |
|
C30H50O |
426.7 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CC=C3C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN006150 |
Euponin |
euponin; DTXSID70415122; 70469-59-9; CHEBI:4942; C09449 |
C20H24O6 |
360.4 |
CC=C(C)C(=O)OC1CC(=C2CC3C(C2C4C1C(=C)C(=O)O4)(O3)C)CO |
|
TCMBANKIN006198 |
zymostrol |
CHEBI:18252; EINECS 204-880-9; LMST01010066; 128-33-6; (3S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-10,13-dimethyl-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C05437; 5-alpha-Cholesta-8,24-dien-3-beta-ol; delta8,24-Cholestadien-3beta-ol; Zymosterol; 5alpha-Cholesta-8,24-dien-3beta-ol |
C27H44O |
384.64 |
CC(CCC=C(C)C)C1CCC2C1(CCC3=C2CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN006208 |
Ailantone |
C08747; 2H-1,11c-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10(3H,6ah)-dione, 1,3a,4,7,7a,11,11a,11b-octahydro-8,11a-beta-dimethyl-3-methylene-1-alpha,2-beta,11-beta-trihydroxy-; AIDS-026407; Picrasa-3,13(21)-dien-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1.beta.,11.beta.,12.alpha.); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1beta,11beta,12alpha)-; 981-15-7; Ailanthone; AIDS026407; Ailanthone (7CI); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1-beta,11-beta,12-alpha)- |
C20H24O7 |
376.4 |
CC1=CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O |
|
TCMBANKIN006223 |
Enhydrin |
enhydrine; BDBM50377905; enhydrin; CHEMBL206765; D0J7XB |
C23H28O10 |
464.46 |
CC1C(O1)(C)C(=O)OC2C3C(C4C(O4)(CCC=C(C2OC(=O)C)C(=O)OC)C)OC(=O)C3=C |
|
TCMBANKIN006312 |
10α-cucurbita-5,24-diene-3β-ol |
|
|
426.8 |
|
|
TCMBANKIN006672 |
arnicolide C |
arnicolide c |
C19H26O5 |
334.41 |
CC1CC2C(C(C(=O)O2)C)C(C3(C1C=CC3=O)C)OC(=O)C(C)C |
|
TCMBANKIN006865 |
lanost-8-en-3beta-ol |
24,25-Dihydrolanosterol; C05109; LMST01010087; CHEBI:28113; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhexyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
C30H52O |
428.73 |
CC(C)CCCC(C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN007023 |
stigmast-7-enol |
|
C29H46O |
410.67 |
CCC(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN007145 |
14-acetoxy-7beta-senecioyloxy-notonipetranone |
|
|
406.57 |
|
|
TCMBANKIN007152 |
ELTANOLONE |
Eltanolonum [INN-Latin]; Pregnanolone; 3.alpha.,5.beta.-Epimeric pregnanolone; Pregnanolone II; CHEBI:1712; 3.alpha.-Hydroxy-5.beta.-tetrahydroprogesterone; Eltanolone [INN]; 5.beta.-Pregnan-20-one, 3.alpha.-hydroxy-; WLN: L E5 B666TJ A1 E1 FV1 OQ; 3alpha-Hydroxy-5beta-tetrahydroprogesterone; 5beta-Pregnan-20-one, 3alpha-hydroxy- (8CI); NSC 82867; BRN 4785659; SKF 6455; (3alpha,5beta)-3-hydroxypregnan-20-one; 3alpha-Hydroxy-5beta-pregnan-20-one; 5beta-Pregnan-3alpha-ol-20-one; 3alpha,5beta-Epimeric pregnanolone; 3-alpha-Hydroxy-5-beta-pregnan-20-one; Pregnan-20-one, 3-hydroxy-, (3alpha,5beta)-; NSC82867; 128-20-1; 1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 3.alpha.-Hydroxy-5.beta.-pregnan-20-one; Pregnan-3alpha-ol-20-one; Eltanolona [INN-Spanish]; 5-beta-Pregnan-20-one, 3-alpha-hydroxy- |
C21H34O2 |
318.49 |
CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN007258 |
Yamogenin |
WQLVFSAGQJTQCK-CAKNJAFZSA-N; (25S)-spirost-5-en-3beta-ol; NSC 226132; LMST01080045; AC1L9BVW; AC-8895; S00020; (2R,5'S)-5'-tetramethylspiro[[?]-2,2'-tetrahydropyran]ol; Jamogenin; Neodiosgenin; AKOS025402417; CHEBI:10086; Spirost-5-en-3-ol, (3beta,25S)-; SCHEMBL6040875; CHEMBL400807; C08918; yamogenin; ZINC8234229; 512-06-1; 25-epi-Diosgenin |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN007694 |
p-mentha-1(7)-dien-8-ol |
|
|
152.26 |
|
|
TCMBANKIN007735 |
songbeisine |
Songbaisine |
C27H41NO3 |
427.62 |
CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5C(=O)C4=C3C)C)O)C)NC1 |
|
TCMBANKIN007977 |
Amarolide |
AIDS-026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2.alpha.,11.alpha.)-; (2alpha,11alpha)-2,11-Dihydroxypicrasane-1,12,16-trione; 29913-86-8; amarolide; AIDS026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2alpha,11alpha)-; (2.alpha.,11.alpha.)-2,11-Dihydroxypicrasane-1,12,16-trione |
C20H28O6 |
364.43 |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)O)C)C)O |
|
TCMBANKIN007988 |
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methylhept-6-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
(3S,5S,9R,10S,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethyl-hex-5-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methyl-hept-6-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5S,9R,10S,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethylhex-5-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|
412.77 |
|
|
TCMBANKIN008033 |
macrostemonoside f_qt |
|
|
416.71 |
|
|
TCMBANKIN008283 |
Anemarsaponin G_qt |
|
|
430.69 |
|
|
TCMBANKIN008366 |
2- methyl-5-(5 ' -hydroxy-1 ' ,5 ' -dimethyl-3 ' -hexenyl)phenol |
|
|
232.4 |
|
|
TCMBANKIN008373 |
(20r,24r)-24,25-epoxy-3-beta-(beta-d-xylopyranosyloxy)-9,19-cyclolanost-7-ene-16,23-dione_qt |
|
|
468.74 |
|
|
TCMBANKIN008398 |
cimilactone b_qt |
|
|
456.68 |
|
|
TCMBANKIN008667 |
21-O-Methyl-5,14-pregndiene-3β,14β,17β,21-tetrol-20-one |
|
|
362.56 |
|
|
TCMBANKIN008688 |
przewalskin a |
|
C23H30O6 |
402.5 g/mol |
CC(C)C1=CC2=C(C(=O)C(=C1O)C(=O)C)C34CCCC(C3C(C2OC4O)O)(C)C |
|
TCMBANKIN008878 |
Anemarsaponin B_qt |
|
C45H74O18 |
903.06 |
|
|
TCMBANKIN008947 |
16-oxo-mansumbin-3(28),13(17)-dien-3-oic acid |
|
C22H32O3 |
344.5 g/mol |
CC(=C)C1CCC2(C(C1(C)CCC(=O)O)CCC3=CC(=O)CC32C)C |
|
TCMBANKIN009220 |
epimansumbinol |
|
|
316.58 |
|
|
TCMBANKIN009244 |
13657-68-6 |
Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))-; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-ylcyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethylcyclodec-6-ene-1,4-dione; 6-Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))- (9CI); Germacr-1(10)-ene-5,8-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-yl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-quinone |
C15H24O2 |
236.35 |
CC1CCC=C(CC(=O)C(CC1=O)C(C)C)C |
|
TCMBANKIN009488 |
pinocarvone |
|
C10H14O |
150.22 |
CC1(C2CC1C(=C)C(=O)C2)C |
|
TCMBANKIN009557 |
lathosterol |
cholest-7-en-3beta-ol; delta(sup 7)-Cholestenol; (3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; ST5331314; 5alpha-Cholest-7-en-3beta-ol; (3-beta,5-alpha)-Cholest-7-en-3-ol; 5-alpha-Cholest-7-en-3-beta-ol; gamma-Cholesterol; C01189; CHEBI:17168; Cholest-7-en-3-ol, (3-beta,5-alpha)- (9CI); Cholesterin [German]; LMST01010089; (3S,5S,9R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 7-Cholesten-3-beta-ol |
C27H46O |
386.65 |
CC(C)CCCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN009752 |
ZINC04081604 |
(8S,9S,10R,13S,14R,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C21H30O2 |
314.46 |
|
|
TCMBANKIN009826 |
sarcostin |
18607-76-6; C17770; (3S,9R,10R,12R,13S,14R,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta(a)phenanthrene-3,8,12,14,17-pentol; CHEBI:81323; Pregn-5-ene-3,8,12,14,17,20-hexol, (3beta,12beta,14beta,17alpha,20S)-; Sarcostin |
C21H34O6 |
382.49 |
CC(C1(CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)O)C)O)O)O |
|
TCMBANKIN009895 |
Z-6,8',7,3'-diligustilide |
|
|
380.52 |
|
|
TCMBANKIN009926 |
ergosta-7,22-dien-3-one |
(22E,24R)-ergosta-7,22-dien-3 β-one; Ergosta-7,22-dien-3-one |
C28H44O |
396.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C |
|
TCMBANKIN010316 |
16-hydroperoxymansumbin-13(17)-en-3β-ol |
|
|
348.58 |
|
|
TCMBANKIN010351 |
Glycoside K_qt |
Glycoside H1_qt |
|
318.55 |
|
|
TCMBANKIN010402 |
aldosterone |
|
C21H28O5 |
360.4 g/mol |
CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C=O)O |
|
TCMBANKIN010419 |
Gypenoside XXIX_qt |
Gypenoside XXIV_qt |
C41H68O12 |
752.97 |
|
|
TCMBANKIN010574 |
Gitoxigenin |
CHEBI:38105; ST5308210; .delta.(20,22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; 5beta,20(22)-Cardenolide-3beta,14,16beta-triol; MEGxp0_001900; 16.beta.-Hydroxydigitoxigenin; gitoxigenin; ZINC03978407; 5.beta.-Card-20(22)-enolide, 3.beta.,14,16.beta.-trihydroxy-; .delta.20,(22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; NSC407807; 16.beta.-Hydroxydisitoxigenin; 3beta,14,16beta-Trihydroxy-5beta,20(22)-cardenolide; 3beta,14,16beta,21-Tetrahydroxy-20(22)-norcholenic acid lactone; 4-[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 545-26-6; Card-20(22)-enolide, 3,14,16-trihydroxy-, (3.beta.,5.beta.,16.beta.)-; NCI60_003893; G4635_SIGMA |
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O |
|
TCMBANKIN010599 |
EINECS 213-897-0 |
(20R,25R)-Spirost-5-en-3beta-yl acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN010665 |
Inumakilactone E |
37886-71-8; inumakilactone e |
C19H24O7 |
364.39 |
CC(CO)C1=C2C(C3C4C(CCC(C4(C2=CC(=O)O1)C)O)(C(=O)O3)C)O |
|
TCMBANKIN010698 |
Gypenoside XXVIII_qt |
|
|
416.71 |
|
|
TCMBANKIN010764 |
methyl (4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-3,11-diketo-4,4,10,13,14-pentamethyl-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; (4R)-4-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester |
C28H42O6 |
474.63 |
|
|
TCMBANKIN010795 |
Yibeissine |
3,11-dihydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-5-one; AC1NSSZ8; 22,26-imino-17,23-oxidojerv-12-en-6-oxo-3β,11α-diol; yibeissine |
C27H41NO4 |
443.62 |
CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5C(C4=C3C)O)C)O)C)NC1 |
|
TCMBANKIN010855 |
4alpha,24-dimethylcholesta-7,24-dienol |
|
C29H48O |
412.7 g/mol |
CC1CCCC2(C1CC=C3C2CCC4(C3CCC4C(C)CCC(=C(C)CO)C)C)C |
|
TCMBANKIN011072 |
Volon |
ZINC03882036; Triamcinolon; Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; Fluoxyprednisolone; BRN 2341955; STOCK1N-56723; 9alpha-Fluoro-16alpha-hydroxyprednisolone; EU-0101179; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Tiamcinolonum [INN-Latin]; Triamcinolona [INN-Spanish]; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-dione; BSPBio_000140; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI); (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyethanoyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; Prestwick0_000120; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1, 4-pregnadiene-3,20-dione; Aristocort; 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Triamcinolone; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-; SK-Triamcinolone; Triamcinlon; EINECS 204-718-7; AIDS-124117; HSDB 3194; Rodinolone; WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ; NSC 13397; 9.Alpha.-Fluoro-11.beta.,16.alpha.,17, 21-tetrahydroxypregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; NCGC00021580-05; Kenacort (TN); NCI60_000750; NSC13397; Triamcinolonum [INN]; Prednisolone, 9-fluoro-16alpha-hydroxy-; 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone; Vetalog; Kenacort-A; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-17-glycoloyl-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; Lopac0_001179; Cinolone-T; Delphicort; Ledercort; BPBio1_000154; Prestwick2_000120; AIDS124117; 124-94-7; MLS000028542; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Prednisolone, 9-fluoro-16.alpha.-hydroxy-; MLS001066543; SPBio_002079; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9-alpha-Fluoro-16-alpha-hydroxyprednisolone; Aristocort Tablets; Pregna-1,4-diene-3, 20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-; 83474-03-7; Triamcinolone (JP15/USP); Triamcinolone [USAN:BAN:INN:JAN]; 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione; Triam-Tablinen; T6376_SIGMA; Celeste; Prestwick1_000120; 4-08-00-03629 (Beilstein Handbook Reference); 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione; Prestwick3_000120; Prestwick_438; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha); Adcortyl; 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; Omcilon; 287334_ALDRICH; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11-beta,16-alpha)-; Triamcet; Kenacort; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-; D00385; Triamcinalone; SMR000058333; CL 19823; 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; Kenacort-AG; Tricortale; nchembio.2007.53-comp7; SMP1_000300 |
C21H27FO6 |
394.43 |
CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O |
|
TCMBANKIN011625 |
ergosta-7,22-diene-3β-ol |
(22e,24r)-ergosta-7,22-dien-3beta-ol |
C28H46O |
398.7 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN011650 |
Siegesmethyletheric acid |
siegesmethylethericacid; siegesmethyletheric acid |
|
334.55 |
CC12CCCC(C1CCC34C2CCC(C3)C(C4)COC)(C)C(=O)O |
|
TCMBANKIN011785 |
3-O-beta-D-Glucopyranosyl betulinic acid-28-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside_qt |
|
|
454.76 |
|
|
TCMBANKIN011818 |
kryptogenin |
|
C27H42O4 |
430.62 |
CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
|
TCMBANKIN011967 |
Gypenoside XXVII_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN011980 |
darutigenol B |
|
C20H34O3 |
322.48 |
|
|
TCMBANKIN011998 |
protostemotinine |
|
C23H29NO6 |
415.48 |
CC1CC(OC1=O)C2CCC34N2CCCCC3=C(C(=O)C45C(=C(C(=O)O5)C)OC)C |
|
TCMBANKIN012468 |
Tripdiotolnide |
tripdiotolnide |
|
360.44 |
C.CC(C)C12C(O1)C(C3=C(C2O)C(=O)CC4C3(CCC5=C4COC5=O)C)O |
|
TCMBANKIN012498 |
cyanin |
LMPK12010113; Cyanidin 3,5-diglucoside; cyanine; Cyanin |
C27H31O16+ |
611.5 g/mol |
C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O |
|
TCMBANKIN012501 |
Suaveolic acid |
(1R,4aS,7S)-8-hydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,5,6,7,8,9,10,10a-decahydrophenanthrene-1-carboxylic acid; suaveolic acid; suaveolicacid; AC1NT0M7 |
C20H32O3 |
320.47 |
CC(C)C1CCC2=C(C1O)CCC3C2(CCCC3(C)C(=O)O)C |
|
TCMBANKIN012652 |
beta-Cholestanol |
Cholestanol (VAN); 5alpha-Cholestanol; 5alpha-Cholestan-3beta-ol; NSC 18188; ()-Dihydrocholesterol; Dihydrocholesterol; 47129_SUPELCO; Cholestan-3beta-ol; 5alpha-Dihydrocholesterol; 3beta-Hydroxy-5alpha-cholestane; Cholestan-3-ol, (3beta,5alpha)-; 3beta-Hydroxycholestane; EINECS 201-315-8; (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; 5-alpha-Cholestan-3-beta-ol; 29466-38-4; ZINC04262223; D6128_SIGMA; 118167-50-3; LMST01010077; (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C27H48O |
388.67 |
CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
|
TCMBANKIN012742 |
sessilifoliamide F |
|
C22H31NO7 |
421.5 g/mol |
CCC1C2C(C(C(=O)O2)C)C3(CC(N(C3=O)CCCCC1=O)C4CC(C(=O)O4)C)O |
|
TCMBANKIN013192 |
Meldenin |
[(10R)-17-(furan-3-yl)-7-hydroxy-4,4,10,13-tetramethyl-3-oxo-2,5,6,7,8,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate; AC1NSXXA; meldenin |
C28H38O5 |
454.6 g/mol |
CC(=O)OC1C2C(C(=O)CCC2(C3CCC4(C(CC=C4C3(C1O)C)C5=COC=C5)C)C)(C)C |
|
TCMBANKIN013252 |
Corchoroside A_qt |
|
|
404.55 |
|
|
TCMBANKIN013287 |
eupatorin_qt |
|
|
318.5 |
|
|
TCMBANKIN013297 |
przewalskin b |
|
C20H26O4 |
330.4 g/mol |
CC(C)C1=CC23CCC4C(=CCCC4(C)C)C2OC(=O)C3(C1=O)O |
|
TCMBANKIN013691 |
guggulsterol-VI |
|
C21H32O2 |
316.48 |
|
|
TCMBANKIN014016 |
glycoside E_qt |
|
|
334.55 |
|
|
TCMBANKIN014135 |
ailantinol A |
|
C21H26O8 |
406.43 |
CC1=CC(=O)C(C2(C1CC3C4(C2C(=O)OC4)C(CC(=O)O3)C(C)C(=O)OC)C)O |
|
TCMBANKIN014437 |
glaucoside H_qt |
|
C47H72O20 |
957.06 |
|
|
TCMBANKIN014484 |
laxogenin |
|
C27H42O4 |
430.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(=O)C6C5(CCC(C6)O)C)C)C)OC1 |
|
TCMBANKIN014806 |
polygosides B_qt |
|
|
430.69 |
|
|
TCMBANKIN014925 |
ergosta-7,9(11),22-trien-3β,5α,6α-triol |
|
C28H44O3 |
428.65 |
|
|
TCMBANKIN015084 |
stemonamide |
|
|
329.43 |
|
|
TCMBANKIN015219 |
polygosides A_qt |
3beta,14alpha-dihydroxy-(25S)-sipirost-5-ene; (3beta,14alpha)-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl(1-4)-beta-d-galacopyranosyl-14-hydroxy-(25S)-spirost-5-ene_qt |
|
430.69 |
|
|
TCMBANKIN015221 |
15alpha-Hydroxy-ent-kaur-16-en-19-oic acid |
CCRIS 1516; NSC 332872 |
C20H30O3 |
318.45 |
CC12CCCC(C1CCC34C2CCC(C3)C(=C)C4O)(C)C(=O)O |
|
TCMBANKIN015442 |
ZINC03978781 |
(3S,8R,9R,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9R,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C35H58O6 |
574.83 |
|
|
TCMBANKIN015497 |
atratoglaucoside b_qt |
|
|
374.47 |
|
|
TCMBANKIN015742 |
pseudoprotodioscin_qt |
|
C51H82O21 |
1031.18 |
|
|
TCMBANKIN015744 |
ingenol |
|
C20H28O5 |
348.43 |
CC1CC2C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4O)C)O)O)CO |
|
TCMBANKIN015967 |
periplocymarin_qt |
|
|
390.57 |
|
|
TCMBANKIN016299 |
beta-Sitosterol-beta-D-glucopyranoside_qt |
|
|
398.69 |
|
|
TCMBANKIN016967 |
Shinjulactone B |
|
C19H22O7 |
362.37 |
CC1C2CC(=O)OC3C2(C(=C(C1=O)O)C(C3)(C)C4C(=CC(=O)O4)C)CO |
|
TCMBANKIN017218 |
Periplogenin-3-O-alpha-L-rhamnopyranoside_qt |
|
|
390.57 |
|
|
TCMBANKIN017657 |
4, 7-dimethoxy-5-methylcoumarin |
4,7-dimethoxy-5-methyl-coumarin; 4,7-dimethoxy-5-methyl-2-chromenone; 4,7-dimethoxy-5-methyl-chromen-2-one; 4,7-dimethoxy-5-methylchromen-2-one; 53377-54-1 |
C12H12O4 |
220.22 |
CC1=CC(=CC2=C1C(=CC(=O)O2)OC)OC |
|
TCMBANKIN018095 |
cycloartenone |
Cycloartenone; CYCLOARTENONE; CHEMBL226084; 511-63-7 |
C30H48O |
424.7 |
CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
|
TCMBANKIN018104 |
leonurinine_qt |
leonuridine_qt |
C15H24O9 |
348.35 |
|
|
TCMBANKIN018239 |
Olitoriside_qt |
|
|
404.55 |
|
|
TCMBANKIN018260 |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid |
(2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-enoic acid |
|
470.76 |
|
|
TCMBANKIN019135 |
16-hydroperoxy-3,4-seco-mansumbin-3(28),13(17)- dien-3-oic acid |
|
C22H34O4 |
362.5 g/mol |
CC(=C)C1CCC2(C(C1(C)CCC(=O)O)CCC3=CC(CC32C)OO)C |
|
TCMBANKIN019140 |
14-deoxy-12(R)-sulfoandrographolide |
|
|
414.57 |
|
|
TCMBANKIN019205 |
Cryptogenin |
Cryptogenine; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione; cryptogenin; Cholest-5-ene-16,22-dione, 3beta,26-dihydroxy-, (20S,25R)- (8CI); Cryptogenine [French]; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione [French]; BXC9X8B37J; 3beta,26-Dihydroxycholest-5-ene-16,22-dione; UNII-BXC9X8B37J; NSC 93751; Cholest-5-ene-16,22-dione, 3-beta,26-dihydroxy-, (20S,25R)- (8CI); Cholest-5-ene-16,22-dione, 3,26-dihydroxy-, (3-beta,25R)-; (3-beta,25R)-3,26-Dihydroxycholest-5-ene-16,22-dione |
C27H42O4 |
430.62 |
[H+].CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
|
TCMBANKIN019313 |
pseudo-ginsenosideRT5_qt |
pseudoginsenoside F11_qt; pseudoginsenoside RT5_qt |
C36H62O10 |
654.87 |
|
|
TCMBANKIN019631 |
glaucoside,d_qt |
cynanoside,j_qt; cynanoside,i_qt |
|
376.49 |
|
|
TCMBANKIN019788 |
α-Spinasterol-β-D-glucoside_qt |
|
|
412.77 |
|
|
TCMBANKIN019874 |
(1S,4aS,4bR,7R,10aS)-1,4a,7-trimethyl-7-vinyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid |
(1S,4aS,4bR,7R,10aS)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid |
|
302.5 |
|
|
TCMBANKIN020082 |
4a-formyl-7alpha-hydroxy-1-methyl-8-methylidene-4aalpha,4bbeta-gibbane-1alpha,10beta-dicarboxylic acid |
(1S,2S,3S,4R,8R,9R,12S)-8-formyl-12-hydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.0(1,9).0(3,8)]pentadecane-2,4-dicarboxylic acid; GA19; CHEBI:28731 |
C20H26O6 |
362.42 |
CC1(CCCC2(C1C(C34C2CCC(C3)(C(=C)C4)O)C(=O)O)C=O)C(=O)O |
|
TCMBANKIN020604 |
Gibberellin A44 |
C12308; LMPR01040090 |
C20H26O5 |
346.42 |
CC12CCCC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)O)COC2=O |
|
TCMBANKIN020623 |
cycloartanol |
SCHEMBL455050 |
C30H52O |
428.73 |
CC(C)CCCC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C |
|
TCMBANKIN020717 |
7-oxoroyleanone2 |
|
|
330.46 |
|
|
TCMBANKIN020734 |
Cyclobuxine |
CYCLOBUXINE-D; 9,19-Cyclo-5.alpha.,9.beta.-pregnan-16.alpha.-ol, 14-methyl-3.beta.,20.alpha.-bis(methylamino)-4-methylene-; 9,19-Cyclopregnan-16-ol, 14-methyl-3,20-bis(methylamino)-4-methylene-, (3.beta.,5.alpha.,16.alpha.,20S)-; Cyclobuxine D; C10797; NSC91720; 2241-90-9 |
C25H42N2O |
386.61 |
CC(C1C(CC2(C1(CCC34C2CCC5C3(C4)CCC(C5=C)NC)C)C)O)NC |
|
TCMBANKIN020874 |
sibiricoside B_qt |
|
C50H80O24 |
1065.16 |
|
|
TCMBANKIN020983 |
methyl (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-3,11,15-triketo-4,4,10,13,14-pentamethyl-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester |
|
472.68 |
|
|
TCMBANKIN021242 |
cynanoside,f_qt |
cynanoside,e_qt |
|
392.49 |
|
|
TCMBANKIN021690 |
cynapanoside C_qt |
cynapanoside A_qt |
|
376.49 |
|
|
TCMBANKIN022084 |
Dihydrofukinolide |
dihydrofukinolide |
C22H32O6 |
392.49 |
CCC(C)C(=O)OC1CCC(C2(C1C(C3(C2)C(=C)COC3=O)OC(=O)C)C)C |
|
TCMBANKIN022301 |
tuberostemonine C |
|
C22H33NO4 |
375.5 |
|
|
TCMBANKIN022919 |
Paniculogenin |
paniculogenin; (25S)-5alpha-spirostan-3beta,6alpha,23S-triol; AC1LCU9T; LMST01080021; 16750-37-1 |
C27H44O5 |
448.64 |
CC1CC(C2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)O)C)O)C)C)OC1)O |
|
TCMBANKIN022930 |
methyl (4R)-4-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester; (4R)-4-[(5R,10S,13R,14R,17R)-3,7,11,15-tetraketo-4,4,10,13,14-pentamethyl-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester |
C28H38O6 |
470.6 |
|
|
TCMBANKIN023001 |
(2'R,5'R,6aS,6bS,8aR,8bS,11aR,12aR,12bR)-5',6a,8a-trimethyl-1,3',4',5',6,6a,6b,6',7,8a,8b,9,11a,12,12a,12b-hexadecahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,8(2H,5H)-dione |
|
|
412.62 |
|
|
TCMBANKIN023876 |
14-acetoxy-7beta-angeloyloxy-notonipetranone |
|
|
406.57 |
|
|
TCMBANKIN024140 |
Quassin |
Picrasa-2,12-diene-1,11,16-trione, 2,12-dimethoxy-; 1405-17-0; LMPR01060018; quassin; (3AS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo(de,g)chromene-1,5,11-trione; C08778; 76-78-8; Quassine; 2,12-Dimethoxypicrasa-2,12-diene-1,11,16-trione; EINECS 200-985-9; AIDS026399; NSC 36342; AIDS-026399 |
C22H28O6 |
388.45 |
CC1C=C(C(=O)C2(C1CC3C4(C2C(=O)C(=C(C4CC(=O)O3)C)OC)C)C)OC |
|
TCMBANKIN024329 |
cynanchoside c2_qt |
|
|
474.7 |
|
|
TCMBANKIN024472 |
3β-hydroxy-5α-pregn-16(17)en-20-one-3-O-β-D-xylopyranosyl(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-β-D-galactopyranoside_qt |
|
|
302.55 |
|
|
TCMBANKIN024859 |
evobioside_qt |
|
C35H54O13 |
682.8 |
|
|
TCMBANKIN025993 |
l-Verbenone |
1196-01-6; 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one; ZINC00967601; (1S,5S)-2,7,7-trimethylbicyclo[3.1.1]hept-2-en-4-one; bicyclo[3.1.1]hept-3-en-2-one, 4,6,6-trimethyl-; AI3-23128; (1S,5S)-2,7,7-trimethyl-4-bicyclo[3.1.1]hept-2-enone; Verbenone, (L)-; Pin-2-en-4-one; BB_NC-0220; Bicyclo(3.1.1)hept-3-en-2-one, 4,6,6-trimethyl-, (1S,5S)-; InChI=1/C10H14O/c1-6-4-9(11)8-5-7(6)10(8,2)3/h4,7-8H,5H2,1-3H; NSC 6831; EINECS 214-807-2 |
C10H14O |
150.22 |
CC1=CC(=O)C2CC1C2(C)C |
|
TCMBANKIN026070 |
Shinjulactone K |
94451-22-6; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2.alpha.,11.alpha.,12.alpha.); AIDS-026415; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2alpha,11alpha,12alpha); shinjulactone k; AIDS026415 |
C22H32O7 |
408.49 |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(C(C4CC(=O)O3)C)OC(=O)C)O)C)C)O |
|
TCMBANKIN026219 |
Jolkinolide A |
1H-Oxireno(1,10a)phenanthro(3,2-b)furan-9(7aH)-one, 2,3,4,4a,5,6,11a,11b-octahydro-4,4,8,11b-tetramethyl-, (4aR-(4aalpha,6aS*,7abeta,11aalpha,11bbeta))-; NCI60_035894; 37905-07-0 |
C20H26O3 |
314.42 |
CC1=C2C3C4(O3)CCC5C(CCCC5(C4C=C2OC1=O)C)(C)C |
|
TCMBANKIN026390 |
[(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-spiro[decalin-4,2'-tetrahydropyran]-1-yl] acetate |
acetic acid [(1R,3R,4R,4aS,8aS)-6'-keto-3,4a,8,8-tetramethyl-spiro[decalin-4,2'-tetrahydropyran]-1-yl] ester; [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxospiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxane]-1-yl] acetate; [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxane]-1-yl] ethanoate; acetic acid [(1R,3R,4R,4aS,8aS)-3,4a,8,8-tetramethyl-6'-oxo-1-spiro[decalin-4,2'-tetrahydropyran]yl] ester |
|
336.52 |
|
|
TCMBANKIN026590 |
Diosgenin acetate |
AC1Q5X0O; diosgenin acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN026829 |
polyporusterone,g |
|
|
460.72 |
|
|
TCMBANKIN027322 |
Scillaren A_qt |
|
C36H52O13 |
692.79 |
|
|
TCMBANKIN027473 |
kulinone |
|
C30H48O2 |
440.7 |
CC(CCC=C(C)C)C1C(CC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C)O |
|
TCMBANKIN027559 |
p-mentha-1,5-dien-8-ol |
p-Mentha-1, 5-dien-8-ol |
C10H16O |
152.23 g/mol |
CC1=CCC(C=C1)C(C)(C)O |
|
TCMBANKIN027802 |
sendanolactone |
|
C30H42O4 |
466.65 |
CC(=CCCC1C2C(CC3(C2(CCC4C3=CC(=O)C5C4(CCC(=O)C5(C)C)C)C)C)OC1=O)C |
|
TCMBANKIN027819 |
paryriogenin B |
|
|
438.66 |
|
|
TCMBANKIN028106 |
(16S, 20R)-dihydroxydammar-24-en-3-one |
|
|
472.83 |
|
|
TCMBANKIN028166 |
tirucallane |
|
C30H54 |
414.7 g/mol |
CC(C)CCCC(C)C1CCC2(C1(CCC3C2CCC4C3(CCCC4(C)C)C)C)C |
|
TCMBANKIN028219 |
TNP00001 |
(1Z,6Z)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; NCGC00017159-01; (1Z,6Z)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione |
C21H20O6 |
368.38 |
COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O |
|
TCMBANKIN028617 |
Imperialine-β-N-oxide |
|
|
445.71 |
|
|
TCMBANKIN029045 |
Telocinobufagin |
telocinobufagin |
C24H34O5 |
402.5 g/mol |
CC12CCC(CC1(CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O |
|
TCMBANKIN029162 |
18beta-glycyrrhetinic acid |
AJ-72559; Rhetinic Acid; C02283; GLYCYRRHETINIC ACID; 18-beta-Glycyrrhetinic acid; 1449-05-4; Glycyrrhetic acid; Hidermart; CHEMBL230006; SMR000058239; SR-01000721867-5; NCGC00142473-03; 18beta-Glycyrrhetinic acid, purum, >=97.0% (T); UNII-P540XA09DR; Enoxolone (Glycyrrhetin); 107420-91-7; Enoxolone, Glycyrrhetinic acid; CCRIS 3962; LMPR0106150014; 18beta-Glycyrrhetic acid; 4-10-00-03775 (Beilstein Handbook Reference); BB_NC-0599; HMS2233P23; LS-7417; (3?)-3-Hydroxy-11-oxoolean-12-en-30-oic acid; Opera_ID_1048; D0U8IF; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; NSC-35350; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (8CI); AC-1925; Glycyrrhetinic acid; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxidanyl-13-oxidanylidene-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; HY-N0180; Arthrodont; Hidermart (TN); DTXSID9020669; SR-01000721867-3; MLS002207101; Enoxolona; Glycyrrhetinic acid (JAN); A-Hydroxy-11-oxoolean-12-en-30-olic acid; SR-01000721867-6; Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-; (3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid; subglycyrrhelinic acid; SCHEMBL18540; 471-53-4; Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; BG01168029; FT-0082445; BX-1; Glycyrrhetin; D00156; NCGC00017244-03; 202522-39-2; 18-beta-Glycyrrhetic acid; SR-01000721867-4; Enoxolonum [INN-Latin]; SBB006496; GM-1658; Q-201057; NSC-35347; NSC 35347; (5S,8S,15S,18S,1R,2R,10R,14R,20R)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid; alpha-Glycyrrhetinic acid; Tox21_112726; 130100-EP2295411A1; ZINC19203131; Biosone; D08LGJ; Bio-0549; Enoxolone; 18beta-Glycyrrhetinic acid; 3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid; Enoxolone (Glycyrrhetinic acid); 50510_FLUKA; BDBM50233538; Uralenic acid; NCGC00017244-04; P540XA09DR; 18beta-glycyrrhetic acid; C30H46O4; Jintan; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-; CAS-471-53-4; Tox21_200799; SR-01000721867; Enoxolone (INN); MLS001146949; MLS000028748; [(125)I] RB129; G10105_ALDRICH; (3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid; s2296; CCG-208506; 8055-71-8; EINECS 207-444-6; (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid; Enoxolona [INN-Spanish]; GlycyrrhetinicAcid; 18b-Glycyrrhetic acid; AC1L1UIT; 130100-EP2269977A2; KS-1262; Glycyrrhetinate; Glycyrrhetinic acid [JAN]; (3alpha,5xi,8alpha,9xi,17alpha,18xi)-3-hydroxy-11-oxoolean-12-en-29-oic acid; BC201656; Enoloxone; Enoxolone [INN:BAN:DCF]; 18 beta-glycyrrhetinic acid; 3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid; enoxolone; DSSTox_RID_75722; 18 beta-Glycyrrhetintic Acid; DSSTox_CID_669; 3-Glycyrrhetinic acid; 3beta-hydroxy-11-oxoolean-12-en-29-oic acid; NCGC00181115-01; Enoxolone; STX-352; AKOS016036757; 15301-63-0; G0149; MFCD00003706; ST24038257; Enoxolone, European Pharmacopoeia (EP) Reference Standard; ST056310; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-13-keto-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; AKOS015960428; 471G534; NCGC00258353-01; DB13089; Tox21_110804; CBW; DSSTox_GSID_20669; D0F6IV; MolPort-002-507-130; A827163; (3beta,5beta,14beta)-3-Hydroxy-11-Oxoolean-12-En-29-Oic Acid; 18beta-Glycyrrhetinic acid, 97%; CHEBI:30853; AC-8906; AN-14462; API0002854; BRN 2229654; Glyciram; 18beta-Glycyrrhetinic acid; MCULE-4676598997; 3beta-Hydroxy-11-oxoolean-12-en-30-oic acid; 3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid; BG00824432; Enoxolone [BAN:DCF:INN]; CS-W020624; S00284; Enoxolonum; 299198-00-8 |
C30H46O4 |
470.68 |
CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
|
TCMBANKIN029300 |
campesterol-3-O-β-D-glucopyranoside |
|
C34H58O6 |
562.82 |
|
|
TCMBANKIN029659 |
Poststerone |
(2S,3R,5R,9R,10R,13R,14S,17S)-17-ethanoyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; poststerone; ZINC04081397; 10162-99-9; C08837; (2S,3R,5R,9R,10R,13R,14S,17S)-17-acetyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one |
C21H30O5 |
362.46 |
CC(=O)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O |
|
TCMBANKIN029678 |
Δ7,16,25,26-stigmastatrienol |
Δ7,22,25-triene-3-β-D-glucoside_qt |
|
410.75 |
|
|
TCMBANKIN029998 |
7beta-senecioyloxyoplopa-3(14)Z,8(10)-dien-2-one |
|
|
428.62 |
|
|
TCMBANKIN030056 |
9,19-cyclolanost-24-en-3-ol |
|
C32H52O2 |
468.75 |
CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C |
|
TCMBANKIN030336 |
Jujubasaponin V_qt |
|
|
472.78 |
|
|
TCMBANKIN030343 |
cucurbita-5,24-dienol |
|
|
440.83 |
|
|
TCMBANKIN030487 |
atratoglaucoside,a_qt |
|
|
360.49 |
|
|
TCMBANKIN030666 |
1,2-epoxyfurano-10(15)-germacren-6-one |
|
|
246.33 |
|
|
TCMBANKIN031036 |
cynanversicoside g_qt 2 |
|
|
344.49 |
|
|
TCMBANKIN031104 |
Lokundjoside_qt |
|
C29H44O10 |
552.65 |
|
|
TCMBANKIN031194 |
Ruvoside_qt |
|
C30H46O9 |
550.68 |
|
|
TCMBANKIN031439 |
STOCK1N-70051 |
(3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carboxaldehyde; (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-17-(5-keto-2H-furan-3-yl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde; (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde |
C29H42O9 |
534.64 |
|
|
TCMBANKIN031504 |
ZINC04081584 |
(5S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-5,6,7,8,9,11,12,14,15,16-decahydro-4H-cyclopenta[a]phenanthren-3-one |
C20H30O2 |
302.45 |
|
|
TCMBANKIN031767 |
ganoderiol I |
|
C31H50O5 |
502.73 |
CC(CCC=C(CO)CO)C1CC(C2(C1(CCC3=C2C(CC4C3(CCC(=O)C4(C)C)C)OC)C)C)O |
|
TCMBANKIN032018 |
isofouquierone |
|
C30H50O3 |
458.72 |
CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(CCC4C(C)(CC=CC(C)(C)O)O)C)C)C |
|
TCMBANKIN032021 |
sessilifoliamide I |
|
C22H31NO6 |
405.5 g/mol |
CCC1C2C(C(C(=O)O2)C)C3(C14CCCCN(C4=O)C(C3)C5CC(C(=O)O5)C)O |
|
TCMBANKIN032159 |
myrrhanones B |
|
|
472.78 |
|
|
TCMBANKIN032316 |
acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-1-decalinyl] ester |
[(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]decalin-1-yl] acetate; acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-4-[2-(2-keto-5H-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-decalin-1-yl] ester; [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-2,3,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate; [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(2-oxo-5H-furan-3-yl)ethyl]-2,3,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] ethanoate |
|
378.56 |
|
|
TCMBANKIN033200 |
Lichesterol |
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; C08823; 50657-31-3; Ergosta-5,8,22-trien-3-ol, (3beta,22E)- |
C28H44O |
396.65 |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3=C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN033347 |
Tetrapanoside A_qt |
|
|
426.75 |
|
|
TCMBANKIN033403 |
(3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yloxan-2-one |
(3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yl-oxan-2-one; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-2-tetrahydropyranone; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-tetrahydropyran-2-one; (3R,6S)-3-[(5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-3-keto-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-isopropenyl-tetrahydropyran-2-one |
|
468.74 |
|
|
TCMBANKIN033466 |
zizyphus saponin I_qt |
Zizyphus saponin III_qt; Zizyphus saponin II_qt |
|
472.78 |
|
|
TCMBANKIN034007 |
methyl (4R)-4-[(3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate |
(4R)-4-[(3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid methyl ester; (4R)-4-[(3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester |
C25H42O5 |
422.6 |
|
|
TCMBANKIN034112 |
31-norlanosterol |
|
C29H48O |
412.7 g/mol |
CC1C2CCC3=C(C2(CCC1O)C)CCC4(C3(CCC4C(C)CCC=C(C)C)C)C |
|
TCMBANKIN034317 |
(3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-15,16-dione |
(3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-15,16-quinone |
C22H30O4 |
358.47 |
|
|
TCMBANKIN034338 |
Ineketone |
(4aS,4bS,5S,7S,10aR)-5,10a-dihydroxy-1,1,4b,7-tetramethyl-7-vinyl-3,4,4a,5,6,10-hexahydro-2H-phenanthren-9-one; CHEBI:5920; ineketone; (4aS,4bS,5S,7S,10aR)-7-ethenyl-5,10a-dihydroxy-1,1,4b,7-tetramethyl-3,4,4a,5,6,10-hexahydro-2H-phenanthren-9-one; 62574-18-9; AC1L4MU4; C09110 |
C20H30O3 |
318.45 |
CC1(CCCC2C1(CC(=O)C3=CC(CC(C23C)O)(C)C=C)O)C |
|
TCMBANKIN034639 |
Anemarsaponin C_qt |
|
|
416.71 |
|
|
TCMBANKIN035135 |
Arnicolide D |
|
C19H24O5 |
332.39 |
CC1CC2C(C(C(=O)O2)C)C(C3(C1C=CC3=O)C)OC(=O)C(=C)C |
|
TCMBANKIN035451 |
Shikodonin |
66548-00-3; C09184; shikodonin; DTXSID50331735; CHEBI:9135; AC1L9C88 |
C20H26O6 |
362.42 |
CC12CCCC3(C1C(OC2)O)COC(=O)C45C3C(CC(C4)C(=C)C5=O)O |
|
TCMBANKIN035624 |
lanost-8-enol |
|
|
428.82 |
|
|
TCMBANKIN035659 |
sessilifoliamide E |
|
C22H31NO6 |
405.5 g/mol |
CCC1C2C(C(C(=O)O2)C)C3CC(N(C3=O)CCCCC1=O)C4CC(C(=O)O4)C |
|
TCMBANKIN035745 |
DOG |
3-beta,12,14-Trioxy-carden-(20:22)-olid [German]; Lanadigenin; delta-sup(20:22)-3-beta,12-beta,14,21-Tetrahydroxynorcholenic acid lactone; ZINC03982471; ST056392; HSDB 7108; 3-beta,12,14-Trioxy-digen-(20:22)-olid [German]; SPBio_002885; Prestwick2_000883; Prestwick1_000883; Prestwick3_000883; 5-beta-CARD-20(22)-ENOLIDE, 3-beta,12-beta,14-TRIHYDROXY-; 1672-46-4; BPBio1_000734; Cardogenen-(20:22)-triol-(3-beta,12,14) [German]; 5-18-04-00380 (Beilstein Handbook Reference); Prestwick0_000883; 3beta,12beta,14-trihydroxy-5beta-card-20(22)-enolide; 3-beta,12-beta,14-Trihydroxy-card-20(22)-enolide; BSPBio_000666; Card-20(22)-enolide, 3,12,14-trihydroxy-, (3-beta,5-beta,12-beta)- (9CI); Digoxigenine; (3beta,5beta,12beta)-3,12,14-Trihydroxycard-20(22)-enolide; BRN 0096479; EINECS 216-806-2; 4-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-(3,12,14-TRIHYDROXY-10,13-DIMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-17-YL)-5H-FURAN-2-ONE; CHEBI:42098 |
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CC(C4(C3(CCC4C5=CC(=O)OC5)O)C)O)O |
|
TCMBANKIN036270 |
Heracleifolinoside B_qt |
|
|
486.76 |
|
|
TCMBANKIN036312 |
20-Hexadecanoylingenol |
20-hexadecanoylingenol |
C36H58O6 |
586.94 |
CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
|
TCMBANKIN036360 |
K-STROPHANTHOSIDE_qt |
|
C42H64O19 |
872.95 |
|
|
TCMBANKIN036622 |
(1S,4aS,10aR)-7-isopropyl-1,4a-dimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid |
(1S,4aS,10aR)-7-isopropyl-5,8-diketo-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid; (1S,4aS,10aR)-1,4a-dimethyl-5,8-dioxo-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid |
|
330.46 |
|
|
TCMBANKIN036682 |
ZINC01280365 |
(8S,9S,10R,13S,14R,17S)-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-glycoloyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-(2-hydroxyethanoyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; (8S,9S,10R,13S,14R,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
C21H30O3 |
330.46 |
|
|
TCMBANKIN036851 |
chenodeoxycholic acid |
(3alpha,5beta,7alpha,8xi)-3,7-dihydroxycholan-24-oic acid; 3-alpha,7-alpha-Dihydroxycholanic acid; Anthropodesoxycholic acid; SMP1_000064; 7-alpha-Hydroxylithocholic acid; BSPBio_000190; Spectrum5_002009; JN3; CDCA; Acide chenodeoxycholique [INN-French]; Acidum chenodeoxycholicum [INN-Latin]; (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; 3-alpha,7-alpha-Dihydroxycholansaeure [German]; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)- (9CI); (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid; Chenodesoxycholsaeure [German]; 5.BETA.-CHOLANIC ACID-3.ALPHA., SODIUM SALT; AIDS-045143; CCRIS 2195; Gallodesoxycholic acid; AIDS045143; Chenodiol (USAN); Chenix (TN); Chenix; 7alpha-hydroxylithocholic acid; SODIUM URSO; Prestwick1_000285; Chenic acid; 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-; HSCI1_000210; D00163; chenodeoxycholicacid; Cholan-24-oic acid, 3,7-dihydroxy-, (3-.alpha., 5-.beta., 7-.alpha.)-; Chenodiol [USAN]; Anthropododesoxycholic acid; SPBio_002409; Prestwick0_000285; Anthropodeoxycholic acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-; Chenodeoxycholic acid (JP15/INN); Chenodiol; NSC681066; CHEBI:16755; 474-25-9; Chenodeoxycholic acid; NSC-681066; 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid; SBB002935; BPBio1_000210; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Prestwick2_000285; Acido chenodeoxicholico [INN-Spanish]; LMST04010032; Chendol; C02528; EINECS 207-481-8; Prestwick3_000285; NSC 657949 |
C24H40O4 |
392.57 |
CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C |
|
TCMBANKIN037067 |
β-Cedrene |
beta-cedrene; DYLPEFGBWGEFBB-OSFYFWSMSA-N; CTK8F1427; A-Cedrene; (+)-; (+)-?-CEDRENE; 6QL7ERD5Q1; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R,3aS,7S,8aS)-; AKOS015896901; 546-28-1; KB-62482; (+)-beta-Funebrene; (+)-beta-Cedrene, >=95.0% (sum of enantiomers, GC); 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, [3R-(3.alpha.,3a.beta.,7.beta.,8a.alpha.)]-; UNII-6QL7ERD5Q1; (3R-(3alpha,3Abeta,7beta,8aalpha))-octahydro-3,8,8-trimethyl-6-methylene-1H-3a,7-methanoazulene; 1H-3a,7-Methanoazulene,octahydro-3,8,8-trimethyl-6-methylene-,(3R,3aS,7S,8aS)-; (+)-beta-Cedrene; ZINC59778864; (+)-.beta.-Cedrene; (3R,3aS,7S,8aS)-3,8,8-Trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; .beta.-Cedrene; EINECS 208-898-8; (1S,2R,5S)-8-Methylene-2,6,6-trimethyltricyclo[5.3.1.01.5]undecane; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R-(3alpha,3abeta,7beta,8aalpha))-; beta-Cedrene |
|
204.35 |
|
|
TCMBANKIN037156 |
lilagenin |
|
C27H42O4 |
430.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CC(C(C6)O)O)C)C)C)OC1 |
|
TCMBANKIN037539 |
Yuccagenin |
511-97-7; Yuccagenin; Spirost-5-ene-2,3-diol, (2alpha,3beta,25R)- |
|
430.62 |
|
|
TCMBANKIN037739 |
Helioscopinolide A |
helioscopinolide a |
|
316.4 g/mol |
|
|
TCMBANKIN037811 |
15α-hydroxymansumbinone |
|
|
328.59 |
CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(C(C=C4)O)C)C)C |
|
TCMBANKIN037960 |
Wallichilide |
|
|
412.52 |
|
|
TCMBANKIN037993 |
Lucidenic acid B |
lucidenicacid b |
|
474.59 |
|
|
TCMBANKIN038293 |
progesterone |
Cyclogesterin; Luteovis; Progeffik; (8S,9S,10R,13S,14S,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Gesterol 50; Corlutin; Syngestrets; NCGC00090798-02; D4-Pregnene-3,20-dione; Hormoluton; Pranone; Crinone progesterone gel; Gesterol 100; Prometrium; Proluton; Luteodyn; Prestwick0_000477; Progestasert; SPBio_002553; .delta.4-Pregnene-3,20-dione; Pregnenedione; NSC-9704; P3972_SIGMA; Methylpregnone; 4-Pregnene-3,20-dione; Prolutone; U 3672; Lutocylin; Colprosterone; Utrogest; Lutocylol; CHEBI:17026; SMR000058345; Corporin; Lipolutin; NCGC00090798-01; P8783_SIGMA; Synovex S; ACon1_002078; 3,20-Pregnene-4; Prestwick_411; Progesterone, water-soluble; Cyclogest; progesterone ; Luteal hormone; Prolets; AIDS070516; NCI60_042166; (S)-Pregn-4-en-3,20-dione; 6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione; Prolidon; NSC 64377; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Nalutron; Progesterone [BAN:INN:JAN]; Progesteronum [INN-Latin]; STR; Flavolutan; Percutacrine Luteinique; Prontogest; Lutocyclin M; Akrolutin; Lugesteron; Corlutina; SCHEMBL12237373; ZINC03814383; Gynlutin; Gynoluton; Prestwick3_000477; Lutogyl; Progesterone: 2-hydroxypropyl-beta-cyclodextrin complex; Crinone (TN); Gynolutone; Spectrum5_002053; Gesterol; AIDS-070516; Progestronol; Luteopur; Corpus luteum hormone; Lutoform; Luteol; 6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione; 17alpha-Progesterone; STOCK1N-52522; Progesterona [INN-Spanish]; Hormoflaveine; Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-; Progesterone [Progestins]; Delta(4)-pregnene-3,20-dione; Progesterone: HBC complex; Delta4-Pregnene-3,20-dione; .beta.-Progesterone; Piaponon; Progestrel; Primolut; Gestone; Pregnene-3,20-dione; Syntolutan; NSC64377; MEGxm0_000472; Progesteron; Gelbkoerperhormon; Membrettes; Progestogel; Gestron; EU-0100895; MLS000028517; Prolutin; EINECS 200-350-6; Luteinique; 57-83-0; Progestron; P9776_SIGMA; NCGC00179853-01; Luteol (VAN); Utrogestan; Lutidon; Progesterol; Luteosan; Gestormone; Gestiron; Progesterone; Lutocuclin M; D00066; Endometrin; Lutin; Progestol; Fologenon; C00410; BG01605063; Lucorteum; 8023-13-0; AI3-51682; 8012-32-6; Luteogan; Agolutin; Progesterone (JP15/USP/INN); 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione; MLS000758277; Crinone; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; Luteohormone; S00293; BPBio1_000676; 17.alpha.-Progesterone; Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-; CMC_13406; NSC 9704; NCGC00022185-06; Luteocrin normale; Progestosol; Protormone; (S)-4-Pregnene-3,20-dione; P6149_SIGMA; Luteine; Lutren; P7556_ALDRICH; 257630-50-5; COL-1620; MolPort-001-740-063; SBB012538; delta(sup4)-Pregnene-3,20-dione; NSC9704; component of Cyclogesterin; Syngesterone; FE-999913; Bio-luton; Prestwick1_000477; NCGC00022185-07; nchembio.2007.53-comp14; Pregn-4-ene-3,20-dione; (1S,3BS,9AR,11AS)-1-ACETYL-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-ONE; 753497-20-0; CCRIS 533; Vitarrine; delta(sup 4)-Pregnene-3,20-dione; Progestone; Luteum; Lipo-Lutin; Progestin; Lutociclina; Progesteronum; WLN: L E5 B666 OV MUTJ A1 E1 FV1; Progekan; .delta.(sup4)-Pregnene-3,20-dione; 46665_RIEDEL; AKOS030503393; Projestaject; Lingusorbs; Lucorteum Sol; Lopac0_000895; Lutex; P0130_SIGMA; Prochieve; Corluvite; BSPBio_000614; BRD-A51738545-001-01-0; Prestwick2_000477; Luteostab; Progesterone; 4-Pregnene-3,20-dione; Lutocyclin; Glanducorpin; Prometrium (TN); HSDB 3389; Lutromone; (S)-Progesterone |
C21H30O2 |
314.46 |
CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
|
TCMBANKIN038393 |
vitetrifolin d |
|
C24H38O5 |
406.6 g/mol |
CC1C(C(C2=C(C1(C)CCC(C)(C=C)O)CCCC2(C)C)OC(=O)C)OC(=O)C |
|
TCMBANKIN038665 |
Sytingaldehyde |
|
C9H10O4 |
182.173 |
c1(O[H])c(OC([H])([H])[H])c([H])c(C([H])=O)c([H])c1OC([H])([H])[H] |
|
TCMBANKIN039128 |
Isofucosterol |
C08812; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methylhex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C08821; AIDS113090; 481-14-1; isofucosterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; AIDS-113090; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 18472-36-1; delta5-Avenasterol |
C29H48O |
412.69 |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN039177 |
Trametenolic acid |
trametenolicacid |
|
456.7 |
|
|
TCMBANKIN039180 |
Shinjudilactone |
shinjudilactone |
C20H24O7 |
376.4 |
CC1C2CC(=O)OC3C24COC(=O)C1(C4C5(C(C3)C(=CC(=O)C5O)C)C)O |
|
TCMBANKIN039211 |
Haginin E |
|
|
240.25 g/mol |
|
|
TCMBANKIN039273 |
17-hydroxy-11-deoxy-corticosterone |
|
C21H30O4 |
346.5 g/mol |
CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C(=O)CO)O)C |
|
TCMBANKIN039349 |
Ganoderic acid E |
ganodericacid e |
|
512.63 |
|
|
TCMBANKIN039469 |
gweicurculactone |
(8R)-1,5,8-trimethyl-7,8-dihydro-6H-azuleno[7,6-d]furan-2-one; Azuleno(6,5-b)furan-2(5H)-one, 6,7-dihydro-3,5,8-trimethyl-, (R)-; 123914-43-2 |
C15H16O2 |
228.286 |
C1([H])=C2C(=C(C([H])([H])[H])C(=O)O2)C([H])=C3C(C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[H])=C1C([H])([H])[H] |
|
TCMBANKIN039527 |
lucidenolactone |
|
C28H38O5 |
455 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]2(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)C2([H])[H])C([H])([H])C3=O)[C@@]34C([H])([H])[H])=C4[C@@](
[H])(O[H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O |
|
TCMBANKIN039688 |
Lucidone B |
lucidone b |
|
400.51 |
|
|
TCMBANKIN039808 |
Periplogenin |
3-beta,5,14-Trihydroxy-5-beta-card-20(22)-enolide; periplogenin; 5-beta-Hydroxydigitoxigenin; Desoxostrophanthidin; 4-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 514-39-6; ZINC04023037; STOCK1N-00120; Card-20(22)-enolide, 3,5,14-trihydroxy-, (3-beta,5-beta)- (9CI); 5-beta-CARD-20(22)-ENOLIDE, 3-beta,5,14-TRIHYDROXY- |
|
390.51 |
|
|
TCMBANKIN039963 |
Alisol B |
CHEMBL421220; SMR001397336; alisol b; NCGC00247506-01; alisol B; MLS002473249; HMS2205K03 |
C30H48O4 |
472.7 g/mol |
CC(CC(C1C(O1)(C)C)O)C2=C3CC(C4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)O |
|
TCMBANKIN040077 |
lucidenic acid G |
lucidenicacid g |
C27H40O7 |
476.6 |
CC(CCC(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)CO)C)O)C)C)O |
|
TCMBANKIN040132 |
maristeminol |
|
|
322.54 |
|
|
TCMBANKIN040689 |
ent-Kaur-15-en-17-ol |
Kaur-15-en-17-ol; Ent-kaur-15-en-17-ol; 14696-33-4 |
|
288.47 |
|
|
TCMBANKIN041007 |
Rosenonolactone |
|
|
316.43 |
|
|
TCMBANKIN041519 |
Polyporusterone D |
polyporusterone d |
|
460.65 |
|
|
TCMBANKIN041627 |
isomaistemonine |
|
C23H29NO6 |
415.48 |
CC1CC(OC1=O)C2CCC34N2CCCCC3=C(C(=O)C45C(=C(C(=O)O5)C)OC)C |
|
TCMBANKIN041860 |
hecogenin |
hecogenin; EINECS 207-392-4; BSPBio_000660; ST5309385; 5alpha-Spirostan-12-one, 3beta-hydroxy-, (25R)- (8CI); Prestwick3_000730; 3-beta-Hydroxy-5-alpha-spirostan-12-one; 467-55-0; NSC 115921; BPBio1_000726; C08902; (22R,25R)-3beta-Hydroxy-5alpha-spirostan-12-one; Spirostan-12-one, 3-hydroxy-, (3beta,5alpha,25R)- (9CI) |
C27H42O4 |
431 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C(=O)[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])[C@@]2(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])O2)O3)
[C@]3([H])C4([H])[H])[C@@]45[H])[C@@]5([H])C([H])([H])C6([H])[H])[C@]6([H])C([H])([H])[C@@]1([H])O[H] |
|
TCMBANKIN042009 |
Abridin |
|
|
368.55 |
|
|
TCMBANKIN042151 |
ergosterol peroxide |
ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C56H86O2 |
791 |
O([C@]1([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C
([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C4[H])C([H])([H])C1([H])[H])=C4[H])O[C@]5([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([
H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C6([H])[H])[C@]67[H])C7=C8[H])C([H])([H])C5([H])[H])=C8[H] |
|
TCMBANKIN042621 |
lucidenic acid D1 |
lucidenicacid d1 |
C27H34O7 |
470.55 |
CC(CCC(=O)O)C1CC(=O)C2(C1(C(=O)C(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C |
|
TCMBANKIN042744 |
bruceine I |
bruceine I |
C22H28O10 |
452 |
C1(=O)C([H])([H])[C@](C([H])([H])[H])([C@]2([H])[C@]3([C@@]([C@@](OC3([H])[H])(C(OC([H])([H])C([H])([H])[H])=O)[C@@]([H])(O[H])[C@]2([H])O[H])(O[H])C([H])([H])C(=O)O4)[C@@]4([H])C5([H])[H])[C@]5([H])C
(C([H])([H])[H])=C1O[H] |
|
TCMBANKIN043071 |
ganoderenic acid H |
ganoderenicacid h |
C30H40O7 |
512.63 |
CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C)C(=O)O |
|
TCMBANKIN043273 |
methly lucidenate L |
|
|
488.68 |
|
|
TCMBANKIN043645 |
Lucidone A |
(3S,5R,7S,10S,13R,17S)-17-acetyl-3,7-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthrene-11,15-dione; lucidone a; AC1L44B5 |
|
402.52 |
|
|
TCMBANKIN044018 |
Previtexilactone |
previtexilactone |
|
379 |
|
|
TCMBANKIN044549 |
Vitetrifolin E |
|
|
365 |
|
|
TCMBANKIN044857 |
maistemonine |
maistemonine |
C23H29NO6 |
415 |
O1C(=O)C(C([H])([H])[H])=C(OC([H])([H])[H])[C@@]12C(=O)C(C([H])([H])[H])=C3[C@]24N([C@]([H])([C@]5([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O5)C([H])([H])C4([H])[H])C([H])([H])C([H])([H])C([H])([H
])C3([H])[H] |
|
TCMBANKIN045705 |
polyporusterone G |
polyporusterone g |
C28H44O5 |
460.65 |
CC(C)C(=C)CC(C(C)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O |
|
TCMBANKIN045792 |
Obtusifoliol |
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; 16910-32-0; 4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol; obtusifoliol; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; Ergosta-8,24(28)-dien-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; 4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol; LMST01030101; 4alpha,14alpha-dimethyl-24-methylene-cholest-8-en-3beta-ol; (3S,4S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylenehexyl]-4,10,13,14-tetramethyl-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; (3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol; C01943; 22332-15-6 |
|
426.72 |
|
|
TCMBANKIN045962 |
Lucidenic acid L |
lucidenicacid l |
|
474.59 |
|
|
TCMBANKIN046146 |
Lucidenic acid E1 |
lucidenicacid e1 |
|
474.59 |
|
|
TCMBANKIN046535 |
Lucidenic acid K |
lucidenicacid k |
|
472.57 |
|
|
TCMBANKIN046968 |
fritillaziebinol |
Fritillaziebinol |
ClO |
324.98 |
CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)(CCl)O)C)C |
|
TCMBANKIN047294 |
raddeanin C |
raddeanin c |
C24H34O7 |
434.52 |
|
|
TCMBANKIN047347 |
lucidone C |
lucidone c |
C24H36O5 |
404.54 |
CC(=O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O |
|
TCMBANKIN047384 |
diayangambin |
CTK4E6827; DTXSID10175733; SCHEMBL17385618; AC1L4ZYE; (1r,3ar,4r,6ar)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-,(1R,3aR,4R,6aR)-; Diayangambin; (+)-Diayangambin; AC1Q70YI; (3R,3aR,6R,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1alpha,3abeta,4alpha,6abeta-1H,3H-furo(3,4-c)furan; 21453-68-9; ZINC31477287 |
C24H30O8 |
446.49 |
COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
|
TCMBANKIN047394 |
isoglaucanone |
|
C27H44O |
385 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@](C([H])([H])[H])(C([H])([H])C([H])([H])C2=O)[C@]2([H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([
H])([H])[H])C([H])([H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
|
TCMBANKIN047772 |
isopropylidenkirenol |
|
C23H38O4 |
379 |
[C@@]1([H])(O[H])C([H])([H])[C@@](C([H])([H])[H])([C@@]2([H])C(=C([H])[C@@](C([H])([H])[H])([C@@]3([H])OC(C([H])([H])[H])(C([H])([H])[H])OC3([H])[H])C([H])([H])C2([H])[H])C([H])([H])C4([H])[H])[C@@]4(
[H])[C@@](C([H])([H])O[H])(C([H])([H])[H])C1([H])[H] |
|
TCMBANKIN047925 |
Helioscopinolide C |
helioscopinolide c |
|
330.42 |
|
|
TCMBANKIN048171 |
bruceaketolic acid |
|
C22H28O12 |
484.45 |
|
|
TCMBANKIN048290 |
Siegesesteric acid II |
siegesesteric acid ii |
C22H36O3 |
348.58 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]2([H])[C@]3(C([H])([H])[C@]([H])([C@@](C([H])([H])OC([H])([H])C([H])([H])[H])([H])C3([H])[H])C([H])([H])C2([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])[C@
](C([H])([H])[H])(C(O[H])=O)C1([H])[H] |
|
TCMBANKIN048450 |
xysmalogenin |
|
C23H32O4 |
372.5 |
CC12CCC(CC1=CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O |
|
TCMBANKIN049540 |
Helioscopinolide B |
helioscopinolide b |
|
316.43 |
|
|
TCMBANKIN049686 |
cycloartenol |
CF58DF82-6B90-40E1-B241-3FA99C98DA64; Cycloartenol; 9,19-Cyclolanost-24-en-3-ol, (3beta)-; C01902; 9beta,19-Cyclo-24-lanosten-3beta-ol; SCHEMBL561141; Cycloarterenol; 469-38-5; NSC 670193 |
C30H50O |
426.7 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C |
|
TCMBANKIN049945 |
Picropolygamain |
|
|
352.34 |
|
|
TCMBANKIN050236 |
Asatone |
asatone |
C24H32O8 |
448.51 |
COC1=CC2(C(C3C(=CC2(C(=O)C3(OC)OC)OC)CC=C)C(C1=O)(OC)OC)CC=C |
|
TCMBANKIN058945 |
Isoramanone |
ramanone isoramanone |
C21H32O4 |
348.48 |
CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O |
|
TCMBANKIN058948 |
PLO |
Prestwick_859; Delta5-Pregnen-3beta-ol-20-one; C01953; Pregnenolona [INN-Spanish]; Prestwick3_000546; LMST02030088; BPBio1_000651; P9129_SIGMA; 81630_FLUKA; 3beta-Hydroxy-5-pregnene-20-one; 3beta-hydroxypregn-5-ene-20-one; Prestwick0_000546; Pregn-5-en-20-one, 3beta-hydroxy-; 5-Pregnen-3-beta-ol-20-one; Prestwick1_000546; Pregn-5-en-20-one, 3beta-hydroxy- (8CI); 3beta-Hydroxy-5-pregnen-20-one; Pregnenolone (progesterone precursor); Prestwick2_000546; Pregnenolone (JAN/INN); Spectrum5_002057; 3beta-Hydroxypregn-5-en-20-one; CMC_13393; SPBio_002512; D00143; Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-; Pregnenolonum [INN-Latin]; delta5-Pregnenolone; 3beta-Hydroxy-Delta5-pregnen-20-one; BSPBio_000591; CHEBI:16581; 5-Pregnen-3beta-ol-20-one; ZINC03861150; Pregn-5-en-20-one, 3-beta-hydroxy-; 3-beta-Hydroxypregn-5-en-20-one; Pregn-5-en-3beta-ol-20-one; Delta5-Pregnene-3beta-ol-20-one; PREGNENOLONE; ST5308463; (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE; 5-Pregnenolone; 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol; EINECS 205-647-4; 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 145-13-1; NSC 1616; Pregn-5-ene-3beta-ol-20-one; 116907-59-6; Pregn-5-en-20-one, 3-hydroxy-, (3beta)- |
C21H32O2 |
316.5 g/mol |
CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059120 |
Ostreasterol |
(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Ergosta-5,24(28)-dien-3beta-ol (8CI); (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethyl-4-methylenehexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-methylene-cholest-5-en-3beta-ol; Ergosta-5,24(28)-dien-3beta-ol; NSC 232664; 24-Methylenecholesterol; LMST01030099; Ergosta-5,24(28)-dien-3-ol, (3beta)- (9CI); (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 474-63-5; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Chalinasterol |
C28H46O |
398.66 |
CC(C)C(=C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059149 |
Ergosterol peroxide |
2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C28H44O3 |
428.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
|
TCMBANKIN059249 |
CLR |
5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N |
C27H46O |
386.65 |
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059272 |
diisobutyl phthalate |
di-isobutyl phthalate;ST5405544; diisobutyl benzene-1,2-dicarboxylate; benzene-1,2-dicarboxylic acid diisobutyl ester; Di-iso-butyl phthalate; 80130_FLUKA; Isobutyl phthalate; bis(2-methylpropyl) benzene-1,2-dicarboxylate; (C4-C13) Branched alkyl alcohols, phthalic anhydride ester; ZINC00388318; EINECS 201-553-2; NSC15316; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; Diisobutyl phthalate; 152641_ALDRICH; EINECS 273-157-8; 68951-39-3; C15205; AI3-04278; Phthalic acid, diisobutyl ester; BRN 2054802; NCGC00091360-01; NSC 15316; WLN: 1Y1&1OVR BVO1Y1&1; 4-09-00-03177 (Beilstein Handbook Reference); Diisobutylester kyseliny ftalove [Czech]; Hexaplas M/1B; 1,2-Benzenedicarboxylic acid, C4-13-branched alkyl esters; AI3-04278 (USDA); Kodaflex DIBP; 68955-80-6; Hatcol DIBP; HSDB 5247; CCRIS 6193; di-l-butyl phthalate (DIBP); Di(i-butyl)phthalate; SMR000112470; MLS000516002; 84-69-5; Palatinol IC |
C16H22O4- C6H4[CO2CH2CH(CH3)2]2 |
278.34 g/mol |
CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C |
|
TCMBANKIN059284 |
delta 5-Pregnenetriol |
(3S,8R,9S,10R,13S,14S,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol; 903-67-3; 5-Pregnene-3beta,17alpha,20alpha-triol; Pregn-5-ene-3,17,20-triol, (3beta,20S)-; Pregn-5-ene-3beta,17alpha,20alpha-triol; 5-pregnene-3β,17α,20α-triol |
C21H34O3 |
334.49 |
CC(C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O)O |
|
TCMBANKIN059337 |
CHD;cholalic acid;cholicacid |
5beta-Cholanic acid, 3alpha,7alpha,12alpha-trihydroxy- (7CI); cholic acid; 3alpha,7alpha,12alpha-Trihydroxycholanic acid; 81-25-4 (FREE ACID); CHOLATE; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoic acid; (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-beta-cholanic acid; (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; Colalin; C9377_SIGMA; SMR000112165; 3.alpha.,7.alpha.,12.alpha.-Trihydroxy-5.beta.-cholanic acid; AIDS017669; 5.beta.-Cholan-24-oic acid, 3.alpha.,7.alpha.,12.alpha.-trihydroxy-; MLS001066422; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3alpha,5beta,7alpha,12alpha)- (9CI); AIDS-017669; Cholic acid (8CI); Cholalic acid; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3-alpha,5-beta,7-alpha,12-alpha)-; Cholsaeure; C1129_SIGMA; ST024722; Spectrum5_002005; 5beta-Cholanic acid-3alpha,7alpha,12alpha-triol 5beta-Cholic acid; Cholalin; 17beta-[1-Methyl-3-carboxypropyl]etiocholane-3alpha,7alpha,12alpha-triol; 73163-53-8 (NA SALT); NSC-6135; 81-25-4; 3-&alpha,7-&alpha,12-&alpha-trihydroxy-5-&beta-cholanate; (3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-Trihydroxycholan-24-oic acid sodium salt; (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid; NSC6135; CHEBI:16359; C00695; LMST04010001;cholic acid;cholic acid |
C24H40O5 |
408.57;408.6 g/mol |
CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C |
|
TCMBANKIN059352 |
lanosterol |
LAN; (3beta)-lanosta-8,24-dien-3-ol; L5768_SIGMA; ZINC03870056; ST5309405; CHEBI:16521; Lanosta-8,24-dienol; 79-63-0; LMST01010017; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; lanosta-8,24-dien-3beta-ol; (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol; Botalan base 138; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.)-; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 8,24-Lanostadien-3beta-ol; L1504_SIGMA; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; Lanster; C01724; NSC60677; LANOSTEROL; Lanosterin; 3beta-Hydroxy-8,24-lanostadiene; Lanosta-8,24-dien-3.beta.-ol |
C30H50O |
426.72 g/mol |
CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
|
TCMBANKIN059402 |
Sitosterol alpha1 |
|
C30H50O |
426.72 |
CC=C(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4C)O)C)C)C(C)C |
|
TCMBANKIN059403 |
Fucosterol |
|
C29H48O |
412.7 g/mol |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN059404 |
Guggulsterone |
|
C21H28O2 |
312.45 |
CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
|
TCMBANKIN059464 |
7-oxodihydro karounidiol |
|
C30H48O3 |
456.7 g/mol |
CC1(C(CCC2(C1CC(=O)C3=C2CCC4(C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C)O)C |
|
TCMBANKIN059509 |
rabdosinatol |
|
C20H30O4 |
334.45 |
CC1(C2CC(C34C(C2(CCC1=O)C)CCC(C3O)C(=C)C4O)O)C |
|
TCMBANKIN059511 |
Benihinal |
|
C10H14O |
150.22 g/mol |
CC1(C2CC=C(C1C2)C=O)C |
|
TCMBANKIN059642 |
Kirenol |
|
C20H34O4 |
338.48 |
CC1(CCC2C(=C1)CCC3C2(CC(CC3(C)CO)O)C)C(CO)O |
|
TCMBANKIN059643 |
sandaracopimaric acid |
|
C20H30O2 |
302.5 g/mol |
CC1(CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)C=C |
|
TCMBANKIN059664 |
NCI60_035895 |
|
C20H26O4 |
330.42 |
CC1(CCCC2(C1CCC34C2C=C5C(=C(C(=O)O5)CO)C3O4)C)C |
|
TCMBANKIN059901 |
p-xylene |
|
C8H10 |
106.17 |
CC1=CC=C(C=C1)C |
|
TCMBANKIN060077 |
17-oxycorticosterone |
|
C21H30O4 |
346.5 g/mol |
CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C(=O)CO)O)C |
|
TCMBANKIN060079 |
14-deoxy-11-oxoandrographolide |
|
C20H28O5 |
348.4 g/mol |
CC12CCC(C(C1CCC(=C)C2C(=O)CC3=CC(=O)OC3)(C)CO)O |
|
TCMBANKIN060093 |
gamabufotalin |
|
C24H34O5 |
402.5 g/mol |
CC12CCC(CC1CCC3C2C(CC4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O |
|
TCMBANKIN060095 |
Gitoxigenin |
|
C23H34O5 |
390.51 |
CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O |
|
TCMBANKIN060104 |
paristerone |
|
C27H44O7 |
480.6 g/mol |
CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O |
|
TCMBANKIN060106 |
Cynotoxin |
|
C23H32O6 |
404.5g/mol |
CC12CCC3C(C1(CCC2C4=CC(=O)OC4)O)CCC5(C3(CCC(C5)O)C=O)O |
|
TCMBANKIN060132 |
Hypodiolide A |
|
C20H30O3 |
318.45 |
CC12CCCC3(C1CCC45C3CCC(C4)C(C5)(C)O)COC2=O |
|
TCMBANKIN060394 |
Amarolide 11-acetate |
|
C22H30O7 |
406.5 g/mol |
CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)OC(=O)C)C)C)O |
|
TCMBANKIN060428 |
Peimisine |
|
C27H41NO3 |
427.6 g/mol |
CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 |
|
TCMBANKIN060475 |
Pennogenin |
|
C27H42O4 |
430.6 g/mol |
CC1CCC2(C(C3(C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)O)C)OC1 |
|
TCMBANKIN060491 |
EINECS 213-897-0 |
|
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
|
TCMBANKIN060507 |
gitogenin |
|
C27H44O4 |
432.64 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)O)O)C)C)C)OC1 |
|
TCMBANKIN060543 |
Chinova acid;quinovic acid |
|
C30H46O5 |
486.68 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C(=O)O)C(=O)O |
|
TCMBANKIN060623 |
tussilagin |
|
C23H34O5 |
390.51 |
CCC(=CC(=O)OC1CC(C2C(C1=C)CC(=O)C2C(C)OC(=O)C)C(C)C)C |
|
TCMBANKIN060674 |
Δ7-stigmasterol |
|
C29H48O |
412.69 |
CCC(C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN060683 |
delta7-Stigmastenone-3;7-stigmastenone-3 |
|
C29H48O |
412.69 |
CCC(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C)C(C)C |
|
TCMBANKIN060693 |
Sitogluside |
|
C35H60O6 |
576.85g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
|
TCMBANKIN060748 |
oxotuberostemonine |
|
C22H31NO5 |
389.54 |
CCC1C(C2C(C(=O)OC23CC(N4C3=C1CCCC4)C5CC(C(=O)O5)C)C)O |
|
TCMBANKIN060958 |
oleic acid;cis-oleic acid;oleinic acid |
|
C18H34O2 |
282.46 |
CCCCCCCCC=CCCCCCCCC(=O)O |
|
TCMBANKIN061011 |
1-tridecene; Tridecylene; tridecene |
|
C13H26 |
182.35 |
CCCCCCCCCCCC=C |
|
TCMBANKIN061091 |
stearic acid |
|
CH3(CH2)16COOH |
284.5 g/mol |
CCCCCCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN061784 |
lirioresinol b dimethyl ether |
1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-; C24H30O8; ( )-O,O-Dimethyllirioresinol B; 1H,3H-Furo(3,4-c)furan, 3aalpha,4,6,6aalpha-tetrahydro-1alpha,4alpha-bis(3,4,5-trimethoxyphenyl)-; ( )-Yangabin; Yangabin; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5)-trimethoxyphenyl)-, 1alpha,3aalpha,4alpha,6aalpha)-; CCRIS 8944; Lirioresinol B dimethyl ether; O,O-Dimethyllirioresinol B; lirioresinol b dimethyl-ether; Lirioresinol B, dimethyl-; LS-70759; (1S-(1alpha,3aalpha,4alpha,6aalpha))-isomer of epiyangambin; Lirioresinol B, O,O-dimethyl-; (- )-lirioresinol B; ACon1_001856; (1R,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; MEGxp0_001363; CTK4E6827; DTXSID10175733; SCHEMBL17385618; AC1L4ZYE; (1r,3ar,4r,6ar)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-,(1R,3aR,4R,6aR)-; Diayangambin; (+)-Diayangambin; AC1Q70YI; (3R,3aR,6R,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1alpha,3abeta,4alpha,6abeta-1H,3H-furo(3,4-c)furan; 21453-68-9; ZINC31477287; yangambin; C10894; ZINC04098936; (1S,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; 13060-14-5; Yangambin; diayangambin |
C24H30O8 |
446.5 g/mol |
COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
滇IICP备16009434号-1 |
Dai SX Lab